Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 8701-8710 of 11995

Page
per page
  1. AZD4547
    A8350 AZD4547
    Target: FGFR
    Summary: FGFR inhibitor
      ≥23.2 mg/mL
  2. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: IGF-IR/IR/ALK inhibitor, ATP-competitive
      ≥26.65 mg/mL
  3. Nocodazole
    A8487 Nocodazole
     8 Citation
    Target: Microtubules/Tubulins
    Summary: microtubule polymerization inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.066 mg/mL
  4. Silodosin
    A8521 Silodosin
    Summary: α1-adrenoceptor antagonist
      ≥24.78 mg/mL
  5. TAK-285
    A8528 TAK-285
    Target: EGFR|HER2
    Summary: HER2/EGFR(HER1) inhibitor
      ≥27.4 mg/mL
  6. ZIP (SCRAMBLED)
    A8830 ZIP (SCRAMBLED)
    Summary: PKMζ inhibitor
      ≥192.8 mg/mL
  7. IQ 3
    B9015 IQ 3
    Summary: Selective JNK3 inhibitor
      <6.83 mg/mL
  8. Indirubin
    B3672 Indirubin
    Target: Cyclin-Dependent Kinases|GSK-3
    Summary: cyclin-dependent kinases and GSK-3β inhibitor
      insoluble in H2O; insoluble in H2O; insoluble in EtOH; ≥13.1 mg/mL
  9. NMS-1286937
    B4094 NMS-1286937
    Target: PLK
    Summary: PLK1 inhibitor, orally bioavailable
      insoluble in H2O; insoluble in EtOH; ≥13.33 mg/mL
  10. Losmapimod
    B4620 Losmapimod
     1 Citation
    Summary: p38 MAPK inhibitor, orally active
      insoluble in EtOH; insoluble in H2O; ≥19.15 mg/mL

Items 8701-8710 of 11995

Page
per page